BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7204716)

  • 1. Vancomycin therapy for serious staphylococcal infections in chronic hemodialysis patients.
    Bierman MH; Needham-Walker CA; Hammeke M; Egan JD
    J Dial; 1980; 4(4):179-84. PubMed ID: 7204716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of falsely elevated vancomycin concentrations in end-stage renal disease.
    Kim JS; Perkins RJ; Briceland LL; Tobin EH
    Ann Pharmacother; 1999 Jan; 33(1):116-8. PubMed ID: 9972400
    [No Abstract]   [Full Text] [Related]  

  • 3. Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia.
    Masur H; Francioli P; Ruddy M; Murray HW
    Clin Nephrol; 1983 Aug; 20(2):85-8. PubMed ID: 6616979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin for staphylococcal shunt site infections in patients on regular haemodialysis.
    Eykyn S; Phillips I; Evans J
    Br Med J; 1970 Jul; 3(5714):80-2. PubMed ID: 5428782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcal sepsis in patients on chronic hemodialysis regimens: intravenous treatment with vancomycin given once weekly.
    Barcenas CG; Fuller TJ; Elms J; Cohen R; White MG
    Arch Intern Med; 1976 Oct; 136(10):1131-4. PubMed ID: 971012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of therapeutic drug monitoring of vancomycin in patients with chronic hemodialysis
.
    Mahmoud LB; Chaabouni Y; Ghozzi H; Feriani H; Hakim A; Kharrat M; Marrakchi C; Sahnoun Z; Jmaa MB; Zeghal K; Hachicha J
    Clin Nephrol; 2017 Oct; 88(10):198-204. PubMed ID: 28793955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic and therapeutic problem of infected arteriovenous fistula for hemodialysis-case report].
    Kade G; Wierzbicki P; Prokopiuk M; Dziekiewicz M; Wańkowicz Z
    Pol Arch Med Wewn; 2001 Nov; 106(5):1055-8. PubMed ID: 12026519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
    Barth RH; DeVincenzo N
    Kidney Int; 1996 Sep; 50(3):929-36. PubMed ID: 8872968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology and efficacy of vancomycin for staphylococcal infections in children.
    Schaad UB; Nelson JD; McCracken GH
    Rev Infect Dis; 1981; 3 suppl():S282-8. PubMed ID: 7342292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcal epidermidis infection of a hemodialysis button-graft complex controlled by vancomycin for 11 months.
    Gault MH; Costerton JW; Paul MD; Parfrey PS; Purchase LH
    Nephron; 1987; 45(2):126-8. PubMed ID: 3561622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent changes in vancomycin use in renal failure.
    Vandecasteele SJ; De Vriese AS
    Kidney Int; 2010 May; 77(9):760-4. PubMed ID: 20182415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin dosing in patients on intermittent hemodialysis.
    Vandecasteele SJ; De Vriese AS
    Semin Dial; 2011; 24(1):50-5. PubMed ID: 21338394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Serum Trough Concentrations and High Vancomycin Minimum Inhibitory Concentration in Methicillin-Sensitive Staphylococcus aureus From Hemodialysis Patients in Brazil.
    Vitória MPD; Alvarenga CGS; Vasconcellos Filho LM; Birro JCT; Barbosa MC; Ferreira MAM; Schuenck RP; Nunes APF; Santos KVD
    Ther Drug Monit; 2019 Feb; 41(1):38-43. PubMed ID: 30520829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agranulocytosis induced by vancomycin in an ESRD patient on CAPD.
    Jo YI; Yoon JH; Shin SY; Chang WC; Kim BK; Jin CJ; Song JO
    Korean J Intern Med; 2004 Mar; 19(1):58-61. PubMed ID: 15053046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin redistribution: dosing recommendations following high-flux hemodialysis.
    Pollard TA; Lampasona V; Akkerman S; Tom K; Hooks MA; Mullins RE; Maroni BJ
    Kidney Int; 1994 Jan; 45(1):232-7. PubMed ID: 8127014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
    Mounier M; Benevent D; Denis F
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous bacterial peritonitis in terminal renal failure.
    Cengiz CK
    Clin Nephrol; 2007 Oct; 68(4):258-61. PubMed ID: 17969496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin penetration into CSF during treatment of patients receiving hemodialysis.
    Nolan CM; Flanigan WJ; Rastogi SP; Brewer TE
    South Med J; 1980 Oct; 73(10):1333-4, 1338. PubMed ID: 7434044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
    Ariano RE; Fine A; Sitar DS; Rexrode S; Zelenitsky SA
    Am J Kidney Dis; 2005 Oct; 46(4):681-7. PubMed ID: 16183423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.